Review of outcomes of combination therapy using yttrium 90 radioembolization and sorafenib/nivolumab for HCC with hepatic vein or IVC invasion

Review of outcomes of combination therapy using yttrium 90 radioembolization and sorafenib/nivolumab for HCC with hepatic vein or IVC invasion

Background A systematic review of the outcomes of combination therapy using Yttrium 90 radioembolization (Y90) and sorafenib/nivolumab for patients with hepatocellular carcinoma (HCC), with hepatic vein (HV) or inferior vena cava (IVC) invasion. The aim of this study is to summarise the results of d...

Full description

Bibliographic Details
Main Authors: Shiqi Chung, Apoorva Gogna, Sivanathan Chandramohan, Richard Lo, Farah Gillan Irani, Nanda Venkatanarasimha
Format: Article
Language:English
Published: SAGE Publishing 2023-01-01
Series:Proceedings of Singapore Healthcare
Online Access:https://doi.org/10.1177/20101058231154666

Similar Items

Similar Items